TD Cowen Reiterates Buy Rating on Takeda Pharmaceutical (TAK) Ahead of 'Key Upcoming Readouts'
Tweet Send to a Friend
TD Cowen analyst Michael Nedelcovych reiterated a Buy rating and $16.00 price target on Takeda Pharmaceutical (NYSE: TAK).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
